Towards improved thrombolytic therapy.
Collen
D
D
Center for Molecular and Vascular Biology, University of Leuven, Belgium.
D016255:Anistreplase / Q000627:therapeutic use; D000925:Anticoagulants / Q000627:therapeutic use; D006801:Humans; D009203:Myocardial Infarction / Q000188:drug therapy; D010960:Plasminogen Activators; D010975:Platelet Aggregation Inhibitors / Q000627:therapeutic use; D012008:Recurrence; D013300:Streptokinase / Q000627:therapeutic use; D015912:Thrombolytic Therapy / Q000639:trends; D013997:Time Factors; D010959:Tissue Plasminogen Activator / Q000627:therapeutic use
D000925:Anticoagulants; D010975:Platelet Aggregation Inhibitors; D016255:Anistreplase; D013300:Streptokinase; D010960:Plasminogen Activators; D010959:Tissue Plasminogen Activator